News | April 28, 2022
Thermo Fisher Scientific expands R&D facility in Hyderabad
This facility will design & develop instruments, perform product reliability performance testing and verification
This facility will design & develop instruments, perform product reliability performance testing and verification
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand
Covaxin was earlier approved for children 12-18 years of age
It is a multi-speciality healthcare brand which delivers a hassle-free experience for all types of cosmetic procedures and elective surgeries with personalized care
Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment
With one of the most diverse lung cancer development programs, Novartis is focused on investments to advance the science, drive treatment and make an impact on patients
The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences
Subscribe To Our Newsletter & Stay Updated
